Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC

Precision and Ease-of-Use Characterize New Line of Microcentrifuges

By BiotechDaily International staff writers
Posted on 30 Jul 2013
Image: The Microfuge 20 micro-centrifuge (Photo courtesy of Beckman Coulter Life Sciences).
Image: The Microfuge 20 micro-centrifuge (Photo courtesy of Beckman Coulter Life Sciences).
A new line of microcentrifuges was designed to meet the specific requirements of a wide range of research applications while being efficient and easy to use.

The Beckman Coulter Life Sciences (Indianapolis, IN, USA) Microfuge 20 and 20R microcentrifuges are compact instruments that provide flexibility and reliable, precise performance whether in refrigerated (the Microfuge 20R) or nonrefrigerated (Microfuge 20) mode of operation. These microcentrifuges are intended for a wide range of biotech research applications including nucleic acid and protein preparation; pelleting, extractions, purifications, concentrations, phase separations and receptor binding; and rapid sedimentation of protein precipitates, particulates, and cell debris. An easy-to-use interface facilitates entry and recall of up to 10 user-defined programs.

Samples can be processed at speeds up to 15,000 rpm (20,627 x g) and the temperature in the Microfuge 20R can be adjusted over a range of -10 to +40 degrees Celsius. Fixed angle rotors are made of polypropylene or aluminum and offer capacities of 24 or 36 microcentrifuge tubes or four PCR tube strips.

“The Microfuge 20 series provides researchers with an accurate, reliable, and durable microcentrifuge,” said David Rolwing, centrifuge product manager at Beckman Coulter Life Sciences. “Strong performance and ergonomic features combine in these units to provide confidence and efficiency.”

Related Links:
Beckman Coulter Life Sciences




Channels

Genomics/Proteomics

view channel
Image: Bacteriophage EFDG1 visualized by transmission electron microscopy (TEM) at a magnification of 20,000–30,000 times. Note that some phages are still bound to remains of the dead bacteria (Photo courtesy of the Hebrew University of Jerusalem).

Bacteriophage Therapy Eliminates Multidrug Resistant Bacterial Infections

Bacteriophage therapy has been shown to be an effective approach for treating infections caused by drug-resistant strains of the bacterium Enterococcus faecalis. E. faecalis, a bacterium inhabiting... Read more

Drug Discovery

view channel
Image: Molecular model of the protein Saposin C (Photo courtesy of Wikimedia Commons).

Nanovesicles Kill Human Lung Cancer Cells in Culture and in a Mouse Xenograft Model

Nanovesicles assembled from the protein Saposin C (SapC) and the phospholipid dioleoylphosphatidylserine (DOPS) were shown to be potent inhibitors of lung cancer cells in culture and in a mouse xenograft model.... Read more

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Business

view channel

Roche Acquires Signature Diagnostics to Advance Translational Research

Roche (Basel, Switzerland) will advance translational research for next generation sequencing (NGS) diagnostics by leveraging the unique expertise of Signature Diagnostics AG (Potsdam, Germany) in biobanks and development of novel NGS diagnostic assays. Signature Diagnostics is a privately held translational oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.